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Influenza A viruses (IAV) still pose a threat to animals and humans. Currently, M2 
protein ion channel inhibitors and neuraminidase inhibitors are the two main drugs 
for treating IAV infections by interrupting virus assembly or release respectively, 
but the emergence of viral resistance was a concern for their long term uses. In this 
study, the inhibition effect of alpha-lipoic acid (α-LA) on IAV propagation has been 
evaluated in vitro. The results showed that α-LA inhibited IAV replication in 
MDCK cells at 2mM, and also reduced nucleus translocation of nuclear factor κB 
(NF-κB) p65 at the concentration above 1mM. Additionally, it was found that 
caspase-3 activity was remarkably inhibited and type I interferons (IFNs) were up-
regulated following α-LA treatment. This study indicated that α-LA might be a 
potential anti-influenza virus agent worthy of further investigations. 
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INTRODUCTION 
 
Alpha-Lipoic Acid (α-LA) naturally exists in both 
animal and plant cells as a cofactor for mitochondrial alpha-
keto-dehydrogenase complex. Readily it is taken up by 
various cells, and transformed into a potent metabolic thiol 
antioxidant in mitochondria (Packer et al., 1995). α-LA has 
been suggested to have therapeutic value in pathologies 
associated with redox imbalances, such as diabetic and 
ischemia-reperfusion injury (Mittermayer et al., 2010; 
Connell et al., 2011). In addition, α-LA is shown to inhibit 
matrix metalloproteinases and disease activity by 
preventing the action of nuclear factor κB (NF-κB) rather 
than by acting as an antioxidant in experimental 
autoimmune encephalitis (Marracci et al., 2002). α-LA also 
affects signal transduction events and gene expression 
through redox-sensitive signaling pathways and 
transcription factors, under both normal and abnormal 
conditions (Liu and Ames, 2005; Lee et al., 2008). 
Influenza A virus (IAV) is a negative-stranded RNA 
virus, and belongs to the Orthomyxoviridae family. With 
antigenic drift and genetic shift, IAV exists and spreads to 
poultry, swine, even human population with high diversity 
which  leads  to  pandemic  outbreaks. Currently, vaccines 
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and antiviral  agents  are  two  main available measures to 
control IAV. At present, two types of antiviral agents are 
the most popular: M2 protein ion channel inhibitors and 
neuraminidase inhibitors (Palese and Shaw, 2007). 
However, for both types of antiviral agents, the 
emergence of viral resistance and possibly enhancement 
of viral mutation have been proven (Poland et al., 2009). 
The vaccination of influenza virus is facing a similar 
situation (Pasquato and Seidah, 2008; Peyre et al., 2009). 
Thus, there is still a great need for new therapeutic agents 
to reduce influenza progression and virus transmission. 
Like any other virus, IAV infection results in the 
activation of a variety of intracellular signaling responses 
(Ludwig et al., 2006), including the NF-κB signaling 
pathway (Ludwig and Planz, 2008; Schmolke et al., 
2009). The NF-κB family is regarded as essential 
components of the innate immune response to infectious 
pathogens and its activation is proposed to be a hallmark 
of IAV infection (Hayden et al., 2006). To date, there is 
accumulating evidence that the nuclear translocation of 
p65 indicates the activation of NF-κB is essential for IAV 
infection and propagation (Nimmerjah et al., 2004; 
Schmolke et al., 2009). Such evidence makes new agents 
targeting NF-κB for treating IAV possible. 
As indicated in many previous studies, type I 
interferons (IFNs) are stimulated when the host is 
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challenged with viruses, including IAV (Seo and Hahm, 
2010). Then IFNs activate the inducible expression of 
hundreds of genes to form an “antiviral state” (Boxel-
Dezaire  et al., 2006). Type I IFNs and apoptosis are 
regarded as two important cell-intrinsic antiviral defenses 
(Stetson and Medzhitov, 2006).  
Therefore, we investigated the effect of α-LA on the 
propagation of IAV in MDCK cells. We also studied how 
α-LA affected on nuclear translocation of p65, apoptotic 
caspase activity and type I IFNs expression levels. This 
research aimed at investigating the probability of α-LA to 
be an antiviral agent to IAV. 
 
MATERIALS AND MOTHODS 
 
Virus, cells and challenge test: Virus in this study was 
A/chicken/influenza virus/Fujian/01 (H5N1) (named 
IVFujian01 and kept properly in poultry disease 
laboratory of South China Agricultural University). 
Madin-Darby canine kidney (MDCK) cell line was also 
preserved in the same laboratory. Cells were challenged 
with IVFujian01 strain in IMDM medium (Invitrogen, 
USA) for 1 h at 37°C in a humid atmosphere of 5% CO2. 
The inoculums was aspirated and cells were cultured with 
IMDM supplemented with 2% FBS.  
 
Treatment of α-LA:  The  α-LA powder (Sigma, USA) 
was dissolved in DMSO at a 5mM stock concentration, 
and diluted in serum-free IMDM medium with indicated 
concentrations before use. The final concentration of 
DMSO was 0.3% (v/v). Meanwhile, the medium 
supplemented with 0.3% DMSO was set into as a control. 
MDCK cells were pretreated with different concentrations 
of α-LA for 2 h before IVFujian01 challenge. Thereafter 
α-LA of the same concentration was added to the medium 
to incubate for indicated time.  
 
MTT assay: The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] assay was used to assess the 
cell viability. MDCK monolayers in 96-well plates treated 
with various concentrations (0.125-5mM) of α-LA were 
cultured for 72 h, after which 20 µl of MTT was added to 
each well and incubated at 37°C for 4 h. Subsequently 
DMSO was added and the absorbance was measured at 
570 nm.  
 
Western blotting: Nuclear protein extraction from 
infected MDCK cells with α-LA treatment was 
accomplished with the nuclear extraction kit (Active 
Motif, USA) and the concentration was determined by the 
BCA assay (Novagen, USA), according to the 
manufacturers’ instruction. The nuclear proteins were 
electrophoresed on a 10% sodium dodecyl sulphate-
polyacrylamide (SDS) gel and transferred to 
polyvinylidene fluoride (PVDF) membranes (Millipore, 
USA) with a semidry transfer cell (Bio-Rad Trans-Blot 
SD, USA). After incubating in blocking buffer for 2h, 
membranes were incubated with anti-p65 (Santa Cruz 
Biotechnology, USA) and anti-histone (Beijing 
Biosynthesis Biotechnology, China) at 4ºC overnight. 
Then the membranes were washed and incubated for 1 h 
at room temperature with HRP-conjugated secondary 
antibodies (Beijing Biosynthesis Biotechnology, China). 
Immunoreactive bands were visualized by SuperSignal 
West Pico Chemiluminescent Substrate Trial Kit (Pierce, 
USA) and exposed to X-ray film. 
 
Fluorometric assay of caspase-3 activity: 
Spectrofluorometric assays of proteolytic activity were 
carried out with synthetic fluorogenic substrates 7-amino-
4-trifluoromethyl coumarin (AFC) to measure caspase-3 
activity using BD ApoAlert Caspase Fluorescent Assay 
Kit (Clontech Laboratories, USA). Briefly, cells were 
harvested and lysed in the lysis buffer on ice for 20 min, 
and then centrifuged at 14000 × g for 10 min. Finally, 50 
µl supernatant was added to an equal volume of 2 × 
reaction/DTT buffer supplemented with 5 µl caspase-3 
substrates DEVD-AFC, and incubated at 37°C for 2 h. 
The optical densities at 405 nm for caspase-3 were 
determined. The nanomoles of AFC expressed per hour 
were calculated according to the standard curve. 
 
Real-time PCR: Total RNA was extracted by Trizol 
reagent (Invitrogen, USA), according to the 
manufacturer's instruction. After digested with DNase I 
(Qiagen, Germany) at 37°C for 30 min, 1 µg RNA was 
used for reverse transcriptase reaction with the ReverTra 
Ace qPCR RT Kit (Toyobo, Japan). Amplifications were 
performed with 1 µl cDNA in a total volume of 20 µl with 
SYBR Green Realtime PCR Master Mix (Toyobo, Japan) 
and conducted with the Stratagene Mx3005P QPCR 
system (Stratagene, Netherlands). All reactions were done 
in triplicate. Relative expression fold change was 
calculated by the 2−∆∆CT method and glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH) was used as the 
endogenous reference gene to normalize the level of target 
gene expression. Primers were as follow: IFN-α (forward: 
5’-GCATCATAAAGGAAAGCAAA-3’; reverse: 5’-CT 
GGGCAAGTGTGGGAAC-3’, 141bp); IFN-β (forward: 
5’-TGCCTCAAGGACAGGATAAAC-3’; reverse: 5’–
TCACAAGAAGGTTCTCGACAG-3’, 178bp); GAPDH 
(forward: 5’ -ATGTTTGTGATGGGCGTGA-3’; reverse: 
5’-TGGGTGGCAGTGATGGCA-3’, 167bp). 
 
Plaque assay: Plaque assay was performed to determine 
virus titer. The virulence difference was performed by 
plaque phenotype after treatment of α-LA and infection of 
IVFujian01 strain.  
 
Statistical analysis: All data were subjected to One-Way 
Analysis of Variance (ANOVA) followed by Tukey test 
using the statistical package SPSS 17.0 software (SPSS, 
USA). Differences were considered as statistically 
significant at P value ≤ 0.05. All data were showed as 
mean ± standard errors (SE). 
 
RESULTS 
 
Determination of MDCK cells appropriate 
concentration by MTT assay: MDCK cells were treated 
with various concentrations (0.125-5mM) of α-LA and the 
viability was examined after 72 h. We found that α-LA 
had no significant toxic effect on the cell viability at the 
concentrations ranging from 0.125mM to 2mM (shown in 
Fig. 1). Based on the results, the appropriate concentration 
of α-LA in MDCK cells was supposed to be below 2mM. Pak Vet J, 2012, 32(1): 101-106. 
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Thus, four concentrations were determined for further 
examination: 2mM, 1mM, 0.5mM and 0.1mM.  
 
 
 
Fig. 1: Toxicity analysis of α-LA in MDCK cells. MDCK cells were 
treated with different concentration of α-LA (0.125-5mM) for 72 h and 
the cell viability was measured by MTT assay. Data represents means ± 
SE of triplicate independent experiments. 
 
Nucleus translocation reduction of p65: Western 
blotting results of p65 level in the nucleus at multiple time 
 
points after virus infection were shown in Fig. 2A. 
Challenge with IVFujian01 strain led to gradual 
accumulation of p65 protein in the nucleus over time and 
a peak at 48 hpi. In mock-infected cells, a very weak p65 
protein was observed as expected. Fig. 2B showed the 
influence of α-LA treatment over the p65 level at 48 hpi. 
It revealed that p65 level in nucleus of IVFujian01-
infected cells was not significantly different from that of 
the control while treated with α-LA at the concentration 
below 0.5mM. Interestingly, a particularly weak p65 level 
was observed at the treatment with 1mM α-LA and even 
weaker at 2mM. Furthermore, histone levels were 
detected as a loading control for nuclear samples and did 
not show any diversity between groups.  
 
Activation inhibit of caspase-3: Fold change of caspase-
3 activation of MDCK cells was shown in Figure 3. 
Gradual increase of caspase-3 was induced by IVFujian01 
(Fig. 3A). At 48 hpi, caspase-3 activation was raised more 
than 2-fold and peaked at 72 hpi (3.3-fold). But a 
consistent decline of caspase-3 was observed at the 
IVFujian01-infected cells treated with indicated 
concentrations (0.1-1mM) of α-LA for 48 h (Fig. 3B), 
followed by a little increase of caspase-3 at 2mM. 
 
Fig. 2: Nucleus translocation of p65 in MDCK cells. (A) Nucleus translocation levels of p65 in MDCK cells infected with IVFujian01 at indicated time 
were detected by western blotting. (B) Nuclear extracts from mock and IVFujian01-infected MDCK cells after treatment with or without α-LA at 48 
hpi were prepared, and the effect of different concentration of α-LA on nucleus translocation of p65 was detected. Histone protein was detected as 
loading control. 
 
 
 
Fig. 3: The effect of α-LA on caspase-3 activation. (A) MDCK cells infected with IVFujian01 were harvested and lysed at indicated time, and (B) 
MDCK cells treated with different concentration of α-LA during IVFujian01 infection were harvested and lysed at 48 hpi, then caspase-3 activity was 
estimated as described in Material and Methods. Fold change of caspase-3 activity at different time post infection compared to mock cells. All results 
were presented as the mean±SE of the triplicate experiments and expressed as fold change compared to mock cells. Pak Vet J, 2012, 32(1): 101-106. 
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Fig. 4: The effect of α-LA on type I interferon (IFN-α/β) expression. Real-time PCR analysis was performed to evaluate IFN-α and IFN-β expression 
levels. Fold change was calculated by the 2
–￿￿Ct method and normalized against the expression of the endogenous reference gene GAPDH. All results 
were expressed as mean±SE of the triplicate measurements. (A) Fold change expression levels of IFN-α and IFN-β in IVFujian01-infected compared to 
mock cells at 12, 24 and 48 hpi (B) Fold change expression levels of IFN-α and IFN-β in IVFujian01-infected compared to mock cells after treatment 
with different concentrations of α-LA at 24 hpi. 
 
 
 
Fig. 5: The effect of α-LA impaired IVFujian01 viral replication. MDCK 
cells were treated with different concentration of α-LA during IAV 
infection. Viral supernatant was collected at 48 hpi to perform plaque 
assay. The results were expressed as the mean±SE of the triplicate 
measurements. 
 
Up-regulation of IFN-α and IFN-β:  The expression 
levels of IFN-α and IFN-β in MDCK cells during 
infection with α-LA supplement was shown in Fig. 4. The 
results indicated that expression levels of IFN-α and IFN-
β in IVFujian01-challenged cells were up-regulated than 
10-fold at 12 hpi and 48 hpi, and peaked at 24 hpi (84.7- 
and 13.9-fold, respectively) compared to mock cells (Fig. 
4A). Pre-treatment of cells with increasing concentrations 
of  α-LA for 2 h resulted in a dose-dependent up-
regulation of IFN-β level at 24 hpi. However, α-LA 
significantly increased IFN-α (199-fold) expression at 
1mM compared to mock cells at 24 hpi (Fig. 4B).  
 
Impairment of influenza virus progeny production: 
Plaque assay was taken to investigate the circumstances of 
IVFujian01 viral replication with α-LA treatment as 
shown in Fig. 5. Results indicated that viral replication 
showed no significant difference (all above 10
6 PFU/ml) 
while supplying α-LA at a concentration lower than 1mM, 
but a significant decrease (2.83×10
2 PFU/ml) at 2mM. 
DISCUSSION 
 
The outburst of highly pathogenic influenza 
threatened the public health and the development of 
global poultry industry. Thus, it is an urgent need to 
develop an available and cost-effective antiviral agent for 
treatment and control of the disease. Our study confirmed 
that within the appropriate concentration range for MDCK 
cells,  α-LA of high concentration (2mM in our case) 
prevented IAV propagation effectively. Western blotting 
confirmed that concentration above 1mM of α-LA 
blocked the p65 translocation to nucleus during virus 
infection, which was a critical step in the activation of 
NF-κB pathway. On the other hand, α-LA at a certain 
concentration (1mM in our case) reduced influenza virus-
induced apoptotic caspase-3 activity. The additional 
findings indicated that α-LA up-regulated the expression 
of type I interferon in MDCK cells, especially the 
expression of IFN-α.  
Based on the previous evidence that NF-κB and 
apoptosis were required for efficient influenza virus 
propagation, we gave a proof that the influenza virus 
(IVFujian01) used in our study also evoked NF-κB and 
caspases activities in MDCK cells. Cells with low NF-κB 
activity were demonstrated as resistant to influenza virus 
infection (Nimmerjah et al., 2004). So it becomes 
practical to block NF-κB activation with a specific agent 
as a therapeutic treatment of influenza virus infection. It 
was documented that α-LA inhibited osteoclast 
differentiation by reducing NF-κB DNA binding and 
prevented bone resorption in vivo (Kim et al., 2006). It 
was also reported that α-LA as a therapeutic agent for 
bone erosive diseases and bronchial asthma was primarily 
through its regulation of NF-κB activation. Recently, 
evidence put forward α-LA could inhibit NF-κB activation 
via blocking of MEKK1-MKK4-IKK signaling cascades 
(Lee et al., 2008), or inhibition of IκB-kinase 2 (Ying et al., 
2010). In this study, we confirmed that α-LA inhibited IAV 
propagation through blocking NF-κB activation and its 
inhibitory effect mainly exerted on p65 translocation. Pak Vet J, 2012, 32(1): 101-106. 
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Interestingly, some research reported that α-LA affected the 
NF-κB activation only at the level of DNA binding of 
transcription factor (Kim et al., 2006), while others found 
the inhibition of DNA binding of NF-κB by α-LA through a 
direct redox regulation of the transcription factor (Packer 
and Cadenas, 2011). Therefore, α-LA might employ more 
than one target to inhibit NF-κB activation. As thus, 
whether there is any other mechanism cooperating with the 
inhibition of NF-κB mediated by α-LA in IAV infection is 
still needed to be concerned. 
As α-LA inhibited NF-κB, it is likely to be involved 
in other cellular events, including apoptosis. Recently, 
apoptosis has been realized as a critical anti-viral strategy 
of the host. In host, NF-κB pathway will perform anti- or 
pro-apoptosis during different virus infection. However, 
both these two mechanisms finally result in that virus can 
successful evade the host defense (Schmolke et al., 2009). 
And caspases play a critical role in the apoptotic process 
as cysteinyl proteases. It has been shown that influenza 
virus infection would induce apoptosis and it is dependent 
on caspase activity in MDCK cells (Yang et al., 2009). In 
our study, a peak level of caspase-3 was also detected in 
MDCK cells at 48 hpi. Other findings proved that α-LA 
prevented TNF-α induced apoptosis through inhibiting 
activation of caspases (Severa and Fitzgerald, 2007). To 
further explore the anti-virus properties of α-LA, we 
examined the caspase-3 activation of IVFujian01 infected 
cells with α-LA treatment. We demonstrated that 
supplement of 1mM α-LA, which interfered with the 
activation of NF-κB pathway, led to reduction of 
influenza virus-induced apoptotic caspase-3 activity. It 
was observed that supplement of a higher concentration 
(2mM) of α-LA would not lead to down-regulation of 
caspase activity. This novel finding indicated that the anti-
virus properties of α-LA would only emerge at a certain 
concentration while a high concentration might have 
cellular toxicity to cause cell death during IAV infection.  
The modulation of NF-κB activation also manifests 
gene expression is relevant to innate immunity. Like other 
cytokines, IFNs play critical role in stimulating innate 
responses to viral infection (Lwasaki and Medzhitov, 
2010). The recognition of viruses by the endosomes leads 
to the dimerization of Toll like receptors (TLRs) and 
recruitment of the adaptor proteins via their TIR domains, 
resulting in the assembly of signaling complexes, the 
initiation of signaling cascades and the activation of the 
transcription factors interferon regulatory factor (IRF) 3, 
IRF7, NF-κB, ATF2 and c-Jun. Upon activation, type I 
IFNs, including IFN-α and -β, are induced (Unterholzner 
and Bowie, 2008). It is indicated that NF-κB is required 
for IFN-β while IRF for IFN-α (Randall and Goodbourn, 
2008). Based on our study, we found IFNs induction in 
IVFujian01-infected MDCK cells. This result was 
consistent with the earlier study on influenza virus on 
human endothelial cells (Schmolke et al., 2009). Further 
study indicated α-LA enormously enhanced the IFN-α 
expression which peaked at 24 hpi at the optimal 
concentration of 1mM. These findings indicated that 
certain concentrations of α-LA (1mM and 2mM in our 
study) would trigger the innate immune response at the 
early stage of viral replication. Moreover, as α-LA would 
inhibit NF-κB activation at certain concentrations, IFN-α 
instead of IFN-β, turn to be the primary effector in this 
case. The innate immune response enhancing mechanisms 
involved α-LA would be studied in further research. 
 
Conclusions 
In conclusion, our study demonstrated that α-LA is an 
attractive therapeutic agent candidate for influenza. It 
inhibited IAV propagation in vitro by a mechanism that 
blocking p65 translocation, up modulating of IFN-α and 
reducing apoptosis. Considering that α-LA may have a 
dual biology activity and even more complex mechanisms 
would be involved, further research on its effect and 
dosage in vivo is successor work of our research. 
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